Good afternoon. Thank you so much for coming and for your comments.
We've been having hearings for the last few days. I think people appreciate the spirit of the bill, and we all want good biosafety and biosecurity, but a number of concerns have come to light.
An example is consultation. Was there consultation? With level two labs, which you both mentioned, will this be very expensive? Will it be onerous? Duplication was a concern, particularly in Ontario and B.C. Privacy was also a concern. There were suggestions that perhaps this should go back to consultation and then be brought back to committee with the regulations.
I'd like to begin by asking whether your organization was consulted in this process. How were they consulted?